News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

By Sumeet Singh, Five Rivers RX

Advertisement

Articles by By Sumeet Singh, Five Rivers RX

The current state of suspicious- order monitoring

ByBy Sumeet Singh, Five Rivers RX
November 11th 2019

DEA’s manufacturer and distributor data-collection requirements are changing

PBM hostility to independent pharmacies and small wholesalers

ByBy Sumeet Singh, Five Rivers RX
April 4th 2017

Is the industry’s VAWD accreditation being used for unfair advantage?

Advertisement

Latest Updated Articles

  • PBM hostility to independent pharmacies and small wholesalers
    PBM hostility to independent pharmacies and small wholesalers

    Published: April 4th 2017 | Updated:

  • The current state of suspicious- order monitoring
    The current state of suspicious- order monitoring

    Published: November 11th 2019 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

2

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

3

A 'Beautiful Fake': Pharma Fraudsters Upping Their Game

4

Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies

5

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us